We are live on ! Find out more
BIOC

Biocept, Inc.

Delisted

BIOC was delisted on the 24th of October, 2023.

5 hedge funds and large institutions have $3.28M invested in Biocept, Inc. in 2014 Q1 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+5
Holders Change %
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

BIOC Hedge Fund Activity: Q1 2014 in Review

5 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q1 2014, worth a combined $3.28M.

Buyers outnumbered sellers: 5 funds opened new BIOC positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Garrison Bradford & Associates, opening a new position worth an estimated $1.36M.

  • 5 institutional investors held Biocept, Inc. (BIOC) as of Q1 2014, up from 0 in Q4 2013.
  • Funds reported $3.28M of Biocept, Inc. stock for Q1 2014.
  • 5 funds opened new Biocept, Inc. positions in Q1 2014 and 0 closed out, a net change of +5 holders.
  • The largest Biocept, Inc. buyer in Q1 2014 was Garrison Bradford & Associates, an estimated $1.36M added.

Based on aggregated 13F filings for Q1 2014.